# Variant Bio

**Canonical:** https://apis.io/providers/variant-bio/  
**Website:** https://www.variantbio.com  
**APIs profiled:** 0

Variant Bio is a biotechnology company developing life-saving therapies by studying the genes of people with exceptional health-related traits. Working with partner communities around the world under an ethical, benefit-sharing approach, the company pairs large-scale genomic discovery with data science to turn genetic diversity into novel drug targets across metabolic, cardiovascular and other disease areas. Surfaced as a portfolio company of General Catalyst, Lux Capital and SoftBank Vision Fund and profiled in the API Evangelist network; Variant Bio publishes no public developer/API surface at this time.

## Kin Score — 7.6 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 7.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Variant Bio Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Genomics, Therapeutics, Drug Discovery, Biotechnology, Precision Medicine

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/variant-bio/). Scores are computed from the provider's own public artifacts under a published rubric.